✦ LIBER ✦

Is Short-Term Palliative Care Cost-Effective in Multiple Sclerosis? A Randomized Phase II Trial

✍ Scribed by Irene J. Higginson; Paul McCrone; Sam R. Hart; Rachel Burman; Eli Silber; Polly M. Edmonds

Book ID: 113741758
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 243 KB
Volume: 38
Category: Article
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2009.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon beta-1b is effective in relap

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Paty, D. W.; Li, D.K.B. 📂 Article 📅 1993 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 759 KB

Interferon beta-1b is effective in relap

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Paty, D. W.; Li, D.K.B. 📂 Article 📅 1993 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 759 KB

We performed yearly MRI analyses on 327 of the total 372 patients in a multicenter, randomized, double-blind, placebo-controlled trial of interferon beta-1b (IFNB). Clinical results are presented in the preceding companion paper. Baseline MRI characteristics were the same in all treatment groups. Fi